Literature DB >> 15664958

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.

Marzia Monica Giuliani1, Laura Santini, Brunella Brunelli, Alessia Biolchi, Beatrice Aricò, Federica Di Marcello, Elena Cartocci, Maurizio Comanducci, Vega Masignani, Luisa Lozzi, Silvana Savino, Maria Scarselli, Rino Rappuoli, Mariagrazia Pizza.   

Abstract

GNA 1870 is a novel surface-exposed lipoprotein, identified by genome analysis of Neisseria meningitidis strain MC58, which induces bactericidal antibodies. Three sequence variants of the protein were shown to be sufficient to induce bactericidal antibodies against a panel of strains representative of the diversity of serogroup B meningococci. Here, we studied the antigenic and immunogenic properties of GNA 1870, which for convenience was divided into domains A, B, and C. The immune responses of mice immunized with each of the three variants were tested using overlapping peptides scanning the entire protein length and using recombinant fragments. We found that while most of the linear epitopes are located in the A domain, the bactericidal antibodies are directed against conformational epitopes located in the BC domain. This was also confirmed by the isolation of a bactericidal murine monoclonal antibody, which failed to recognize linear peptides on the A, B, and C domains separately but recognized a conformational epitope formed only by the combination of the B and C domains. Arginine in position 204 was identified as important for binding of the monoclonal antibody. The identification of the region containing bactericidal epitopes is an important step in the design of new vaccines against meningococci.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664958      PMCID: PMC546939          DOI: 10.1128/IAI.73.2.1151-1160.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Reverse vaccinology.

Authors:  R Rappuoli
Journal:  Curr Opin Microbiol       Date:  2000-10       Impact factor: 7.934

2.  Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.

Authors:  K Cartwright; N Noah; H Peltola
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

3.  Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis.

Authors:  Stephen M Prince; Mark Achtman; Jeremy P Derrick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 4.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

5.  A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.

Authors:  D M Granoff; G R Moe; M M Giuliani; J Adu-Bobie; L Santini; B Brunelli; F Piccinetti; P Zuno-Mitchell; S S Lee; P Neri; L Bracci; L Lozzi; R Rappuoli
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

6.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 7.  Vaccine prevention of meningococcal disease, coming soon?

Authors:  S L Morley; A J Pollard
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

8.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

Authors:  H Tettelin; N J Saunders; J Heidelberg; A C Jeffries; K E Nelson; J A Eisen; K A Ketchum; D W Hood; J F Peden; R J Dodson; W C Nelson; M L Gwinn; R DeBoy; J D Peterson; E K Hickey; D H Haft; S L Salzberg; O White; R D Fleischmann; B A Dougherty; T Mason; A Ciecko; D S Parksey; E Blair; H Cittone; E B Clark; M D Cotton; T R Utterback; H Khouri; H Qin; J Vamathevan; J Gill; V Scarlato; V Masignani; M Pizza; G Grandi; L Sun; H O Smith; C M Fraser; E R Moxon; R Rappuoli; J C Venter
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

9.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

10.  Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.

Authors:  C C Peeters; I J Claassen; M Schuller; G F Kersten; E M van der Voort; J T Poolman
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

View more
  45 in total

1.  Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.

Authors:  Andrew D Cox; Frank St Michael; Dhamodharan Neelamegan; Suzanne Lacelle; Chantelle M Cairns; Marzia M Giuliani; Alessia Biolchi; J Claire Hoe; E Richard Moxon; James C Richards
Journal:  Glycoconj J       Date:  2010-10-05       Impact factor: 2.916

2.  Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.

Authors:  Serena Giuntini; Donald C Reason; Dan M Granoff
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

3.  Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.

Authors:  Peter T Beernink; Arunas Leipus; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  A universal vaccine for serogroup B meningococcus.

Authors:  Marzia M Giuliani; Jeannette Adu-Bobie; Maurizio Comanducci; Beatrice Aricò; Silvana Savino; Laura Santini; Brunella Brunelli; Stefania Bambini; Alessia Biolchi; Barbara Capecchi; Elena Cartocci; Laura Ciucchi; Federica Di Marcello; Francesca Ferlicca; Barbara Galli; Enrico Luzzi; Vega Masignani; Davide Serruto; Daniele Veggi; Mario Contorni; Maurizio Morandi; Alessandro Bartalesi; Vanda Cinotti; Donatella Mannucci; Francesca Titta; Elisa Ovidi; Jo Anne Welsch; Dan Granoff; Rino Rappuoli; Mariagrazia Pizza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-06       Impact factor: 11.205

5.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis.

Authors:  Francesca Cantini; Daniele Veggi; Sara Dragonetti; Silvana Savino; Maria Scarselli; Giacomo Romagnoli; Mariagrazia Pizza; Lucia Banci; Rino Rappuoli
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

Review 7.  Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.

Authors:  Jacqueline Sharon; Michael J Rynkiewicz; Zhaohua Lu; Chiou-Ying Yang
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

8.  Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.

Authors:  Francesca Oriente; Vincenzo Scarlato; Isabel Delany
Journal:  J Bacteriol       Date:  2009-11-30       Impact factor: 3.490

9.  Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody.

Authors:  Enrico Malito; Marco Biancucci; Agnese Faleri; Ilaria Ferlenghi; Maria Scarselli; Giulietta Maruggi; Paola Lo Surdo; Daniele Veggi; Alessia Liguori; Laura Santini; Isabella Bertoldi; Roberto Petracca; Sara Marchi; Giacomo Romagnoli; Elena Cartocci; Irene Vercellino; Silvana Savino; Glen Spraggon; Nathalie Norais; Mariagrazia Pizza; Rino Rappuoli; Vega Masignani; Matthew James Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

10.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.